#dermatology

June 26, 2025
PRNewswire
Healthcare, News

Scinai Showcases PC111 Breakthrough as Pincell Scientist Wins Prestigious Italian Dermatology Award

Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company specializing in inflammation and immunology (I&I) biological products and in providing CDMO services through its Scinai Bioservices unit, proudly announces that Dr. Roberta...

April 8, 2025
PRNewswire
Healthcare

Alphyn Announces First Patient Dosed in CLEAR-AD1 Global Phase 2b Clinical Trial Program of Zabalafin Hydrogel for Atopic Dermatitis

Alphyn, a clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics®, announced today that the first patient has been dosed in its CLEAR-AD1 Phase 2b clinical trial of Zabalafin Hydrogel in Australia. The trial will evaluate...